Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Rat dog micro-cap picks... -- Ignore unavailable to you. Want to Upgrade?

To: Bucky Katt who wrote (39834)	4/23/2009 8:57:24 PM
From: RikRichter	Read Replies (1) \| Respond to of 48463

Bio-rat NWBO.OB 1.15 continues to rise in the wake of DNDN. If Michael Murphy of Seeking Alpha is right in his write-up "Is Dendreon a $360 Stock or is That Too Low", DNDN is worth $36 Billion. If NWBO's DC Vax, which uses similar dendritic cell cancer vaccine technology that has shown startingly favorable results for its advanced brain cancer vaccine, can approach this kind of a valuation what would this do to the share price of NWBO and their present $50 Million valuation?: seekingalpha.com